Related Experiment Videos
[Malignant tumors in infancy and childhood]
1Kinderchirurgische Abteilung, Chirurgischen Universitätsklinik Heidelberg.
Summary
Wilms tumor (nephroblastoma) offers a favorable prognosis in children, with 80-90% relapse-free survival. Neuroblastoma, while common, has a poorer outlook, with overall survival around 50% across all stages.
Area of Science:
- Pediatric Oncology
- Cancer Epidemiology
Context:
- Neuroblastoma and Wilms tumor are significant pediatric malignancies.
- Incidence rates show neuroblastoma at 7.2% and nephroblastoma at 6.2% in children (1980-1993).
Purpose:
- To compare the characteristics, staging, treatment, and prognosis of pediatric neuroblastoma and nephroblastoma.
- To highlight the differing outcomes between these two childhood cancers.
Summary:
- Wilms tumor (nephroblastoma) is a staged embryonic mixed tumor with an 80-90% relapse-free survival due to intensive interdisciplinary care.
- Neuroblastoma, a sympathetic nervous system malignancy, has a less favorable prognosis (50% overall survival), with treatment varying by stage (INSS classification).
Impact:
- Wilms tumor represents a highly curable childhood cancer with excellent survival rates.
- Neuroblastoma outcomes remain challenging, particularly in advanced stages, underscoring the need for improved therapeutic strategies.